Skip to main content
Molecular Cancer logoLink to Molecular Cancer
. 2004 Jan 14;3:2. doi: 10.1186/1476-4598-3-2

Retraction: TGFβ1 signaling via aVβ6 integrin

Martin P Kracklauer 1, Christian Schmidt 2,, Guido M Sclabas 2,3
PMCID: PMC324566  PMID: 14723796

The data published in this article [1] and in a subsequent article in Molecular Cancer [2] were generated by myself, the corresponding author, with collaborators in Germany. The data were originally part of a manuscript on which my collaborators were authors and which remains unpublished. When publishing the data in Molecular Cancer, I failed to obtain the agreement from my past collaborators or to acknowledge their contributions, resulting in an unfair representation of their ideas and thoughts. In light of this, I have decided to retract the two papers. I deeply apologize for any inconvenience this may have caused.

Contributor Information

Martin P Kracklauer, Email: mordechai30@hotmail.com.

Christian Schmidt, Email: christian.schmidt@molecular-cancer.org.

Guido M Sclabas, Email: guido.m.sclabas@molecular-cancer.org.

References

  1. Kracklauer MP, Schmidt C, Sclabas GM. TGFβ1 signaling via aVβ6 integrin. Mol Cancer. 2003;2:28. doi: 10.1186/1476-4598-2-28. [DOI] [PMC free article] [PubMed] [Google Scholar] [Retracted]
  2. Luettich K, Schmidt C. TGFβ1 activates c-Jun and Erk1 via aVβ6 integrin. Mol Cancer. 2003;2:33. doi: 10.1186/1476-4598-2-33. [DOI] [PMC free article] [PubMed] [Google Scholar] [Retracted]

Articles from Molecular Cancer are provided here courtesy of BMC

RESOURCES